US · Healthcare

Ocular Therapeutix Inc (OCUL)

Biotechnology

Ocular Therapeutix Inc (OCUL) is listed on US in the Healthcare sector. Industry: Biotechnology. As of 2026-03-23, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for OCUL

P/E ratio

18.00

Ocular Therapeutix Inc (OCUL) — FAQ

What is OCUL's P/E ratio?

The price-to-earnings (P/E) ratio for Ocular Therapeutix Inc (OCUL) is 18.00 (data as of 2026-03-23).

Does Ocular Therapeutix Inc pay a dividend?

Dividend yield is not available in the current snapshot for Ocular Therapeutix Inc (OCUL). Check the MyAverix Finance app for the latest dividend data.

What sector is Ocular Therapeutix Inc in?

Ocular Therapeutix Inc (OCUL) is classified in the Healthcare sector (Biotechnology industry).

What exchange is OCUL listed on?

OCUL is listed on US.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

Abbott Laboratories (ABT) AbbVie Inc. CDR (ABBV) Agilent Technologies Inc. (A1GI34) Aimed Bio (0009K0) Alnylam Pharmaceuticals, Inc. (A1LN34) Alvotech (ALVO) Amgen Inc (AMGN34) argenx SE (A1RG34)